This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

ThermoGenesis Corp. To Announce Fourth Quarter And Fiscal 2013 Year End Results On August 29, 2013

RANCHO CORDOVA, Calif., Aug. 27, 2013 (GLOBE NEWSWIRE) -- ThermoGenesis Corp. (Nasdaq:KOOL), a leading supplier of innovative products that process and store adult stem cells, announced today it will report financial results for the fiscal fourth quarter and year ended June 30, 2013, on Thursday, August 29, 2013.

Company's Conference Call and Webcast

Management will host a conference call Thursday, August 29, 2013 at 2:00 PM Pacific (5:00 PM Eastern) to review the fiscal fourth quarter & year ended results.

The call can be accessed by dialing 1-800-860-2442 within the U.S. or 1-412-858-4600 outside the U.S. and referencing, "ThermoGenesis." Mr. Matthew T. Plavan, Chief Executive Officer, Mr. Dan Bessey, Chief Financial Officer, and Mr. Kenneth Harris, Chairman and Chief Executive Officer of TotipotentRX Corporation will be on the call to discuss the fourth quarter results and other corporate events, followed by a Q&A session. Participants are asked to call the assigned number approximately five minutes before the conference call begins.

To listen to the audio webcast of the call during or after the event, please visit: http://www.thermogenesis.com/company/investor-relations/webcasts-calls/

Replay

A replay of the conference call will be available two hours after the call for the following five business days by dialing 1-877-344-7529 within the U.S. or 1-412-317-0088 outside the U.S. and entering the following account number when prompted ' 385107'.

About ThermoGenesis Corp.

ThermoGenesis Corp. ( www.thermogenesis.com ) is a leading supplier of innovative products and services that process and store adult stem cells for treatment of disease and injury.

CONTACT: Investor Relations
         +1-916-858-5107, or
         Email: ir@thermogenesis.com
         Web site: http://www.thermogenesis.com

ThermoGenesis Corp. Logo

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,826.30 -279.47 -1.54%
S&P 500 2,081.18 -23.81 -1.13%
NASDAQ 4,931.8150 -75.9760 -1.52%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs